UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline – But Still No Draft Law Progress
The One Agency initiative, patient safety, methods of funding and recruitment needs were pressing discussion themes during the MHRA’s April 2022 board meeting held in public.
You may also be interested in...
Graeme Tunbridge is looking forward to a new career with notified body, BSI, after nearly two decades as a civil servant. But where does his departure leave the UK MHRA at a time of critical change?
The MHRA intends to drop around 300 roles as it faces a financial crunch after leaving the EU and other pressures.
The UK devices regulator will prioritize innovation, global best practice and enhanced patient safety and the patient voice, MHRA board chairman Stephen Lightfoot said during the ABHI’s spring regulatory conference. New fees for industry are also on the cards.